Abstract
Background
The purpose of this study was to report the basic profile of the Miyagi Prefecture part of a repeated center-based survey during the second period of the Tohoku Medical Megabank Community-Based Cohort Study (TMM CommCohort Study), as well as the participants’ characteristics based on their participation type in the baseline survey.
Methods
The second period survey, conducted from June 2017 to March 2021, included participants of the TMM CommCohort Study (May 2013 to March 2016). In addition to the questionnaire, blood, urine, and physiological function tests were performed during the second period survey. There were three main ways of participation in the baseline survey: Type 1, Type 1 additional, or Type 2 survey. The second period survey was conducted in the same manner as the Type 2 survey, which was based on the community support center (CSC).
Results
In Miyagi Prefecture, 29,383 (57.7%) of 50,967 participants participated in the second period survey. The participation rate among individuals who had visited the CSC was approximately 80%. Although some factors differed depending on the participation type in the baseline survey, the second period survey respondents in the Type 1 and Type 2 survey groups at baseline had similar traits.
Conclusion
The second period survey of the TMM CommCohort Study provided detailed follow-up information. Following up on the health conditions of the participants will clarify the long-term effects of disasters and contribute to personalized prevention.
Key words: prospective cohort studies, Great East Japan Earthquake, genome cohort
INTRODUCTION
The Tohoku Medical Megabank (TMM) Project, a large-scale genomic cohort research project centered on the Great East Japan Earthquake (GEJE) disaster area, aims to contribute to the reconstruction of medical care and medical institutions in the area and the development of a next-generation medical system that includes drug discovery and personalized medicine.1 The TMM project is conducted in Miyagi and Iwate Prefectures, with the TMM Birth and Three-Generation Cohort Study (The TMM BirThree Cohort Study),2 which is a birth and three-generation cohort study, and the TMM Community-Based Cohort Study (The TMM CommCohort Study), which is a population-based adult cohort study.3
The purpose of the TMM CommCohort Study is to investigate the influence of earthquake-related disaster on health, support local people by providing avenues for the early detection of illness, and provide individualized treatment.3 To date, various results from the baseline survey have been published.4–11 The Miyagi part of the baseline survey of the TMM CommCohort Study was conducted from May 2013 to March 2016, approximately 2 years after the GEJE. The second period survey was conducted approximately 4 years subsequently, from June 2017 to March 2021. The third phase, a detailed center-based repeat survey, started in July 2021 is scheduled to end in March 2026.
There were three main ways to participate in the baseline survey: Participation in the Type 1, Type 1 additional, or Type 2 survey (Table 1).3 Participant characteristics at baseline differed depending on the participation type.3 Details of the differences have been described in a previous paper.3 The second period survey employed the same recruiting method as the Type 2 survey (ie, all participants were asked to visit one of the community support centers [CSC] for a detailed examination). Visiting the CSC allowed participants to undergo detailed physiological functional tests. Therefore, in this profile paper, we investigated the classification of Type 1 without CSC survey, Type 1 with CSC survey, and Type 2 survey since the characteristics of participants at baseline might differ based on whether they visited the CSC or not (Table 1).3
Table 1. Baseline survey participation type.
Based on the baseline survey profile paper3 |
The way of participation | Based on this second period survey profile paper |
The way of participation |
Type 1 survey | Recruited participants at the specific health check-up venues of 28 municipalities. |
Type 1 without CSC survey | Type 1 survey or Type 1 additional survey participants without visiting the CSC. |
Type 1 additional survey | Conducted on different dates from those of the specific health check-up in the municipality because of a limitation with the settings (the size of the venue). |
Type 1 with CSC survey | Type 1 survey or Type 1 additional survey participants with visiting the CSC. Participants voluntarily visited the CSC, after participating in a Type 1 survey or Type 1 additional survey. |
Type 2 survey | Performed at the CSC, which was established by ToMMo in seven areas in Miyagi prefecture. Participants voluntarily visited the CSC. |
Type 2 survey | Same as the baseline profile paper |
CSC, Community Support Centers (Established by ToMMo in seven areas in Miyagi Prefecture).
This study reports the recruitment method, survey variables, and outline of the respondents in the second period survey of the Miyagi Prefecture part of the TMM CommCohort Study. We also compared the baseline characteristics of those who participated in the second period survey with those of participants who did not. Furthermore, the basic characteristics of the participants in the second period survey are shown based on the baseline participation type.
METHODS
Recruitment
We described the details of the TMM CommCohort baseline survey.3 Briefly, the baseline survey was conducted from May 2013 to March 2016, targeting residents of Miyagi Prefecture aged 20 years or older. Miyagi Prefecture suffered great damage from the GEJE that struck on March 11, 2011. The Type 1 survey was performed at specific municipal health checkup sites, and the Type 2 survey was performed at the CSC, which was established by Tohoku University Tohoku Medical Megabank Organization (ToMMo) in seven areas in Miyagi Prefecture (Table 1). Type 2 participants voluntarily visited the CSC. The Type 1 additional survey was conducted on different dates from those of the specific health check-up in the municipality because of a limitation with the settings (the size of the venue). Among Type 1 participation type (Type 1 survey and Type 1 additional survey), the group that did not visit the CSC later was referred to as Type 1 without CSC survey, while the group that visited was referred to as Type 1 with CSC survey (Table 1). Visiting the CSC allowed participants to undergo detailed physiological functional tests that were not performed in the Type 1 without CSC survey. In this study, we investigated the classification of Type 1 without CSC survey, Type 1 with CSC survey, and Type 2 survey because the characteristics of participants at baseline may alter depending on whether or not they visited the CSC.3
The second period survey was conducted by mailing pamphlets to baseline survey participants in the order in which they participated in the baseline survey. Those who wished to participate made reservations via telephone. The secretariat mailed the questionnaire and urine collection kit to the applicant in advance and collected them on the day of participation in the second period survey.
Some participants who could not visit the CSC, mainly due to the spread of coronavirus disease 2019 or poor health, were asked to return only the filled questionnaire. This study examined participants who submitted the questionnaire and blood samples.
After receiving sufficient explanation regarding the study, all participants gave their written informed consent. This study was approved by the Ethical Committee of ToMMo (the first approval: 2012-4-617 and latest approval: 2023-4-004).
Variables
Questionnaire
In addition to basic information such as height, weight, current residence, work, income, family background, medications, and personal and family medical histories, we asked about nursing care status, memory at the time of the earthquake and disaster prevention efforts, social isolation measures (Lubben Social Network Scale [LSNS-6]),12 irritable bowel syndrome (ROME-II modular questionnaire),13,14 food intake (Food Frequency Questionnaire), and eating habits. In addition, on the day of the survey, participants answered questions about physical activity, smoking status, drinking status, depressive symptoms (Center for Epidemiologic Studies Depression Scale [CES-D]),15 psychological distress (Kessler Psychological Distress Scale [K6]),16 and insomnia (Athens Insomnia Scale [AIS]),17 on a tablet (Table 2).
Table 2. Details of the questionnaire and tablet survey at baseline and/or follow-up for the TMM CommCohort study.
Measurement | Measurement lists | Baseline | second period |
Basic information | Sex (C) | ○ | |
Birthday and age (N) | ○ | ||
Body weight/Body height (N) | ○ | ○ | |
Body weight at 20 years old (N) | ○ | ||
Birth weight (C) | ○ | ||
Education (C) | ○ | ||
Degree of house damage from the disaster (C) | ○ | ||
Current residence (C) | ○ | ○ | |
Number of relocations following the GEJE (C) | ○ | ○ | |
Income (C) | ○ | ||
Daily activity | Daily activity (C) | ○ | ○ |
Transportation (C) | ○ | ||
Surrounding environment (park/store) (C) | ○ | ||
Drinking | Drinking status (C) | ○ | ○ |
Drinking frequency (C) | ○ | ○ | |
Amount of drinking (C) | ○ | ○ | |
Smoking | Smoking status (C) | ○ | ○ |
Reasons for quitting smoking (C) | ○ | ○ | |
Passive smoking (C) | ○ | ○ | |
Stress | Perceived stress (C) | ○ | ○ |
Psychological distress (Kessler Psychological Distress Scale [K6]) (C) (N) | ○ | ○ | |
PTSD scale (Impact of Event Scale-Revised [IES-R]) | ○ | ||
PTSD (C) | ○ | ||
Holmes-Rahe Social Readjustment Rating Scale (C) | ○ | ||
Drug, supplements, and health foods | Use of drug, supplements, and health foods (C) | ○ | ○ |
Family | Marital status (C) | ○ | ○ |
Number of children (N) | ○ | ○ | |
Cohabitants (C) | ○ | ○ | |
Caring for the family (C) | ○ | ||
Health status | Current health status (C) | ○ | ○ |
Treatment of hypertension, hyperlipidemia and diabetes mellites (C) | ○ | ○ | |
Medical history (C) | ○ | ○ | |
Dental consultation (C) | ○ | ○ | |
Helicobacter pylori infection/eradication (C) | ○ | ||
Working status | Employment status (C) | ○ | ○ |
Profession (C) | ○ | ||
Engaged industry (C) | ○ | ○ | |
Sleeping | Sleeping time (C) | ○ | ○ |
Insomnia (Athens Insomnia Scale [AIS]) (C) (N) | ○ | ○ | |
Social isolation | Social isolation (Lubben Social Network Scale [LSNS-6]) (C) | ○ | ○ |
Depressive symptoms | Depressive symptoms (Center for Epidemiologic Studies Depression scale [CES-D]) (C) (N) | ○ | ○ |
The Great East Japan | Memory of the earthquake disaster (C) | ○ | ○ |
Earthquake | Experience of damage and loss due to the earthquake (C) | ○ | |
Physical damage caused by the earthquake (C) | ○ | ||
Evacuation behavior (C) | ○ | ○ | |
Participation in disaster drill (past) (C) | ○ | ○ | |
Participation in disaster drill (current) (C) | ○ | ||
For women | About menstruation (C) | ○ | ○ |
Pregnancy/Childbirth (C) (N) | ○ | ○ | |
Health checkup | Participation of health checkup (C) | ○ | |
Vaccination (influenza/pneumococcus) (C) | ○ | ||
Quality of life | Quality of life (EuroQol 5 Dimension) (N) | ○ | ○ |
Irritable bowel syndrome | Irritable bowel syndrome (ROME-II modular questionnaire) (C) | ○ | ○ |
Autism-Spectrum | Autism-Spectrum Quotient (AQ) (C) | ○ | ○ |
| |||
Eating habit | Eating habit (C) | ○ | ○ |
Food intake | Food Frequency Questionnaire (FFQ) (C) (N) | ○ | ○ |
C, categorical data; GEJE, Great East Japan Earthquake; N, numerical data; PTSD, Post-Traumatic Stress Disorder.
Blood and urine tests
The volume of blood collected during the second period survey was 36 mL. Of this, 7 mL was placed in an EDTA 2Na bottle, 7 mL in a sodium heparin bottle, and 9 mL each in two plain bottles. Additionally, 2 mL of blood was used for a complete blood count test and another 2 mL for a blood sugar or HbA1c test. Participants were requested to visit the center on the morning of the survey with a urine sample collected at home. Thereafter, they were requested to bring the urine to the sites or assessment centers. The measurement items are listed in Table 3. In the second period survey, the serum pepsinogen test included in the baseline survey was removed and thyroid-stimulating hormone and C-reactive protein (CRP) tests were added.
Table 3. Details of blood, urine, and other tests at baseline and/or follow-up for the TMM CommCohort study.
Measurement | Measurement lists | Baseline | second period |
Blood | N-terminal pro-B-type natriuretic peptide (NT-proBNP) Glycoalbumin (GA) | ○ | ○ |
Creatinine (CRE) | ○ | ○ | |
Allergen-Specific immunoglobulin E (IgE) antibody test | ○ | ○ | |
Helicobacter pylori antibody test | ○ | ||
Serum pepsinogen (PG) test | ○ | ||
Aspartate aminotransferase (AST) | ○ | ○ | |
Alanine aminotransferase (ALT) | ○ | ○ | |
Gamma-glutamyl transferase (GGT) | ○ | ○ | |
Urea nitrogen (UN) | ○ | ○ | |
Uric acid (UA) | ○ | ○ | |
Glucose | ○ | ○ | |
Triglycerides (TG) | ○ | ○ | |
Total cholesterol (T-Cho) | ○ | ○ | |
Low-density lipoprotein cholesterol (LDL-C) | ○ | ○ | |
High-density lipoprotein cholesterol (HDL-C) | ○ | ○ | |
Complete blood count (CBC) | ○ | ○ | |
Hemoglobin A1c (HbA1c) | ○ | ○ | |
Immunoglobulin E (IgE) test | ○ | ||
Cystatin C | ○ | ○ | |
Thyroid stimulating hormone (TSH) | ○ | ||
C-reactive protein (CRP) | ○ | ||
| |||
Urine | Microalbumin | ○ | ○ |
Creatinine (CRE) | ○ | ○ | |
Sodium | ○ | ○ | |
Chloride | ○ | ○ | |
Potassium | ○ | ○ | |
| |||
Others | Height | ○ | ○ |
Weight and body composition | ○b | ○ | |
Waist circumference | ○ | ○ | |
Touchscreen questionnaire | ○b | ○ | |
Axial length | ○b | ○ | |
Intraocular pressure | ○b | ○ | |
Optical coherence tomography | ○b | ○ | |
Color retinal photography | ○b | ○ | |
Refraction and keratometry | ○b | ○ | |
Hearing acuity | ○b | ○ | |
Respiratory function | ○b | ○ | |
Respiratory impedance | ○b | ○ | |
Estimated central aortic blood pressure, casual blood pressure and heart rate | ○b | ○ | |
Carotid ultrasound imaging | ○b | ○ | |
Calcaneal ultrasound bone mineral density | ○b | ○ | |
Leg extension strength | ○b | ||
Grip strength | ○b | ○ | |
Oral examination | ○b | ○ | |
Oral bacteriological examination | ○b | ○ | |
Home blood pressurea | ○b | ○ | |
Number of steps per daya | ○b | ○ | |
Fraction of exhaled nitric oxide (FeNO) | ○ | ||
Electrocardiograph | ○ | ||
Taste of salt | ○ |
aMeasured for around 10 days.
bMeasured only Type 1 with CSC survey or Type 2 survey participants at the baseline survey.
Physiological tests
Various physiological tests were conducted to evaluate the subjects’ current physical condition in detail (Table 3). In the second period survey, the leg extension strength test performed in the baseline survey was removed, the fraction of exhaled nitric oxide was assessed (Niox Vero; Chest M.I., Inc., Tokyo, Japan), and electrocardiogram (ECG-2500; Nihon Kohden Corporation, Tokyo, Japan) was performed.
Add-on tests
Various collaborative studies are being conducted in addition to the abovementioned tests. There is collaborative research with Yakult Central Institute on lacto-fermented beverages and intestinal flora, and another collaboration with OMRON Healthcare Co., Ltd to produce a urine sodium (Na)/potassium (K) ratio meter, an activity tracker, and a sleep meter.
Death information
Tracking of deceased participants was performed by browsing the basic resident registration of the local government in the following cases: when mail, such as follow-up questionnaires from the TMM CommCohort secretariat, was not delivered; when family members provided an individual’s information; or when information on death-related withdrawal from the National Health Insurance was provided. The basic resident registration was viewed at least once a year when an individual could not be contacted.
Statistical analyses
The characteristics of the second period survey participants were examined according to the participation types in the baseline survey. For each participation type, we divided the group into those who participated in the second period survey and those who did not. Specifically, we examined age, sex, degree of house damage, social factors, including education, marital status, and LSNS-6; lifestyle factors, including smoking, alcoholism, and time spent walking; physical factors, including body mass index (BMI) and medical history; and psychological factors, including perceived stress, K6 score, and CES-D score.
We also examined the association between participation type and second period survey characteristics such as smoking (never-smoker, and ever-smoker), drinking (never-drinker, and ever-drinker), time spent walking (less than 1 hour, or 1 hour or more), BMI (less than 25 kg/m2, or 25 kg/m2 or more), medical history (presence or absence of cancer, stroke, or myocardial infarction), perceived stress (minimal or none, or perceived), psychological distress (K6 score; less than 13, or 13 or more), or depressive symptoms (CES-D score; less than 16, or 16 or more). Multivariate logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) after controlling for potential confounders. The variables considered in the models were age at the second period survey (continuous), sex, education at baseline (16 years or more, 13 to 15 years, 12 years or less, or unknown), marital status at the second period survey (married, single, separated, widowed, or unknown), social isolation at the second period survey (LSNS-6 score; less than 12, 12 or more, or unknown), and situation of disaster damage at baseline (not living in the disaster area or no damage to the house, partial damage to the house, marked damage or destruction of the house, or unknown).
RESULTS
Of 54,952 baseline survey participants, 50,967 continued to consent to the survey as of October 5, 2021. In addition, as of March 2021, 1,053 participants were confirmed dead based on public data. A total of 33,392 participants participated in the baseline Type 1 without CSC survey, and 3,916 participants participated in the baseline Type 1 with CSC survey; 15,343 (45.9%) of the former group and 3,178 (81.2%) of the latter group participated in the second period survey. Further, 10,862 (79.5%) of 13,659 Type 2 survey participants participated in the survey (Figure 1). Out of 50,967 participants, 29,383 (57.3%) participated in the second period survey in Miyagi Prefecture.
Among those who had difficulty visiting the CSC, whom we asked to return the filled questionnaire, 4,752 returned the questionnaire. With the addition of this group, 34,135 participants (67.0%) participated in the second period survey.
Baseline characteristics of the participants according to whether they participated in the second period survey
Regarding the mean age of the participants at baseline, there was a tendency for Type 2 participants to be younger than the other participants. Particularly, Type 2 participants who did not participate in the second period survey were younger than the other participants (Table 4). Type 1 without CSC survey and Type 2 participants who participated in the second period survey were more likely to be married, 60–69 years old, and never-smokers, with fewer depressive symptoms, compared to those who did not participate. Furthermore, regardless of whether or not they participated in the second period survey, Type 1 with CSC survey participants were more likely to have completed at least 16 years of education. Type 2 survey participants were more likely to have experienced partial house damage during the disaster, and their BMI was less than 25 kg/m2 at baseline. There were not many differences in the other variables between those who did or did not participate in the second period survey.
Table 4. Baseline characteristics of participants according to whether or not they participated in the second period survey.
Total subjects at the baseline survey |
Baseline survey participation type | ||||||
| |||||||
Type 1 without CSC survey (N = 33,392) |
Type 1 with CSC survey (N = 3,916) |
Type 2 survey (N = 13,659) |
|||||
| |||||||
second period survey | |||||||
| |||||||
Not participated |
Participated | Not participated |
Participated | Not participated |
Participated | ||
| |||||||
Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | |
Total participants | 50,967 | 18,049 (54.1) | 15,343 (45.9) | 738 (18.8) | 3,178 (81.2) | 2,797 (20.5) | 10,862 (79.5) |
Age at baseline, years | |||||||
Mean (SD) | 59.0 (12.3) | 58.9 (12.2) | 60.2 (11.0) | 60.3 (11.2) | 60.6 (10.1) | 55.1 (16.3) | 57.9 (13.0) |
20–39 | 5,236 (10.3) | 1,966 (10.9) | 1,211 (7.9) | 55 (7.5) | 169 (5.3) | 627 (22.4) | 1,208 (11.1) |
40–49 | 5,471 (10.7) | 1,874 (10.4) | 1,329 (8.7) | 79 (10.7) | 297 (9.4) | 417 (14.9) | 1,475 (13.6) |
50–59 | 8,878 (17.4) | 3,007 (16.7) | 2,481 (16.2) | 110 (14.9) | 578 (18.2) | 430 (15.4) | 2,272 (20.9) |
60–69 | 21,941 (43.1) | 7,739 (42.9) | 7,562 (49.3) | 352 (47.7) | 1,594 (50.2) | 707 (25.3) | 3,987 (36.7) |
≥70 | 9,441 (18.5) | 3,463 (19.2) | 2,760 (18.0) | 142 (19.2) | 540 (17.0) | 616 (22.0) | 1,920 (17.7) |
Sex | |||||||
Male | 18,281 (35.9) | 7,267 (40.3) | 5,753 (37.5) | 220 (29.8) | 957 (30.1) | 912 (32.6) | 3,172 (29.2) |
Female | 32,686 (64.1) | 10,782 (59.7) | 9,590 (62.5) | 518 (70.2) | 2,221 (69.9) | 1,885 (67.4) | 7,690 (70.8) |
Social factors | |||||||
Education | |||||||
16 years or more | 5,893 (11.6) | 1,452 (8.0) | 1,672 (10.9) | 57 (7.7) | 405 (12.7) | 458 (16.4) | 1,849 (17.0) |
13–15 years | 11,984 (23.5) | 3,816 (21.1) | 3,568 (23.3) | 192 (26.0) | 818 (25.7) | 712 (25.5) | 2,878 (26.5) |
12 years or less | 32,090 (63.0) | 12,253 (67.9) | 9,850 (64.2) | 479 (64.9) | 1,899 (59.8) | 1,587 (56.7) | 6,022 (55.4) |
Unknown | 1,000 (2.0) | 528 (2.9) | 253 (1.7) | 10 (1.4) | 56 (1.8) | 40 (1.4) | 113 (1.0) |
Marital status | |||||||
Married | 39,827 (78.1) | 13,721 (76.0) | 12,462 (81.2) | 593 (80.4) | 2,573 (81.0) | 1,967 (70.3) | 8,511 (78.4) |
Single | 4,067 (8.0) | 1,619 (9.0) | 951 (6.2) | 36 (4.9) | 213 (6.7) | 379 (13.6) | 869 (8.0) |
Separate | 2,339 (4.6) | 787 (4.4) | 635 (4.1) | 45 (6.1) | 132 (4.2) | 148 (5.3) | 592 (5.5) |
Widowed | 3,708 (7.3) | 1,301 (7.2) | 1,081 (7.1) | 55 (7.5) | 232 (7.3) | 245 (8.8) | 794 (7.3) |
Unknown | 1,026 (2.0) | 621 (3.4) | 214 (1.4) | 9 (1.2) | 28 (0.9) | 58 (2.1) | 96 (0.9) |
Social isolation (LSNS-6 score) | |||||||
Socially isolated (Less than 12) | 11,811 (23.2) | 4,390 (24.3) | 3,621 (23.6) | 173 (23.4) | 703 (22.1) | 605 (21.6) | 2,319 (21.4) |
Socially integrated (12 or more) | 36,765 (72.1) | 12,456 (69.0) | 11,129 (72.5) | 529 (71.7) | 2,371 (74.6) | 2,048 (73.2) | 8,232 (75.8) |
Unknown | 2,391 (4.7) | 1,203 (6.7) | 593 (3.9) | 36 (4.9) | 104 (3.3) | 144 (5.2) | 311 (2.9) |
Disaster damage situation | |||||||
Not living in the disaster area or No damage to the house |
14,788 (29.0) | 5,391 (29.9) | 4,374 (28.5) | 195 (26.4) | 831 (26.2) | 884 (31.6) | 3,113 (28.7) |
Partial damage to the house | 27,931 (54.8) | 9,657 (53.5) | 8,863 (57.8) | 394 (53.4) | 1,802 (56.7) | 1,338 (47.8) | 5,877 (54.1) |
Marked damage to the house or Destruction of the house |
5,773 (11.3) | 1,837 (10.2) | 1,452 (9.5) | 115 (15.6) | 408 (12.8) | 438 (15.7) | 1,523 (14.0) |
Unknown | 2,475 (4.9) | 1,164 (6.5) | 654 (4.3) | 34 (4.6) | 137 (4.3) | 137 (4.9) | 349 (3.2) |
Lifestyle factors | |||||||
Smoking | |||||||
Never-smoker | 30,851 (60.5) | 10,168 (56.3) | 9,366 (61.0) | 461 (62.5) | 2,144 (67.5) | 1,669 (59.7) | 7,043 (64.8) |
Ex-smoker | 12,349 (24.2) | 4,130 (22.9) | 3,953 (25.8) | 159 (21.5) | 756 (23.8) | 627 (22.4) | 2,724 (25.1) |
Current smoker | 6,816 (13.4) | 3,138 (17.4) | 1,786 (11.6) | 99 (13.4) | 247 (7.8) | 483 (17.3) | 1,063 (9.8) |
Unknown | 951 (1.9) | 613 (3.4) | 238 (1.6) | 19 (2.6) | 31 (1.0) | 18 (0.6) | 32 (0.3) |
Drinking | |||||||
Never-drinker | 22,445 (44.0) | 8,205 (45.5) | 6,673 (43.5) | 340 (46.1) | 1,476 (46.4) | 1,169 (41.8) | 4,582 (42.2) |
Ex-drinker | 1,310 (2.6) | 511 (2.8) | 365 (2.4) | 25 (3.4) | 71 (2.2) | 82 (2.9) | 256 (2.4) |
Current drinker | 26,870 (52.7) | 9,097 (50.4) | 8,224 (53.6) | 367 (49.7) | 1,620 (51.0) | 1,541 (55.1) | 6,021 (55.4) |
Unknown | 342 (0.7) | 236 (1.3) | 81 (0.5) | 6 (0.8) | 11 (0.4) | 5 (0.2) | 3 (0.03) |
Time spent walking | |||||||
1 hour or more | 26,729 (52.4) | 9,575 (53.1) | 8,201 (53.5) | 402 (54.5) | 1,719 (54.1) | 1,389 (49.7) | 5,443 (50.1) |
Less than 1 hour | 21,937 (43.0) | 7,195 (39.9) | 6,394 (41.7) | 298 (40.4) | 1,320 (41.5) | 1,386 (49.6) | 5,344 (49.2) |
Unknown | 2,301 (4.5) | 1,279 (7.1) | 748 (4.9) | 38 (5.2) | 139 (4.4) | 22 (0.8) | 75 (0.7) |
Physical factors | |||||||
BMI | |||||||
Less than 25 kg/m2 | 36,830 (72.3) | 12,436 (68.9) | 11,197 (73.0) | 514 (69.7) | 2,307 (72.6) | 1,996 (71.4) | 8,380 (77.2) |
25 kg/m2 or more | 13,891 (27.3) | 5,594 (31.0) | 4,130 (26.9) | 213 (28.9) | 854 (26.9) | 740 (26.5) | 2,360 (21.7) |
Unknown | 246 (0.5) | 19 (0.1) | 16 (0.1) | 11 (1.5) | 17 (0.5) | 61 (2.2) | 122 (1.1) |
Medical history | |||||||
Cancer | 3,828 (7.5) | 1,278 (7.1) | 1,218 (7.9) | 47 (6.4) | 253 (8.0) | 200 (7.2) | 832 (7.7) |
Stroke | 1,101 (2.2) | 414 (2.3) | 323 (2.1) | 18 (2.4) | 81 (2.5) | 56 (2.0) | 209 (1.9) |
Myocardial infarction, angina | 1,409 (2.8) | 498 (2.8) | 421 (2.7) | 21 (2.8) | 97 (3.1) | 86 (3.1) | 286 (2.6) |
Psychological factors | |||||||
Perceived stress | |||||||
Minimal or none | 12,978 (25.5) | 4,871 (27.0) | 4,054 (26.4) | 167 (22.6) | 771 (24.3) | 592 (21.2) | 2,523 (23.2) |
Significant or moderate | 37,420 (73.4) | 12,785 (70.8) | 11,172 (72.8) | 570 (77.2) | 2,399 (75.5) | 2,180 (77.9) | 8,314 (76.5) |
Unknown | 569 (1.1) | 393 (2.2) | 117 (0.8) | 1 (0.1) | 8 (0.3) | 25 (0.9) | 25 (0.2) |
Psychological distress (K6 score) | |||||||
Absence (Less than 13) | 46,770 (91.8) | 16,231 (89.9) | 14,255 (92.9) | 686 (93.0) | 2,951 (92.9) | 2,506 (89.6) | 10,141 (93.4) |
Presence (13 or more) | 3,085 (6.1) | 1,079 (6.0) | 860 (5.6) | 41 (5.6) | 208 (6.5) | 226 (8.1) | 671 (6.2) |
Unknown | 1,112 (2.2) | 739 (4.1) | 228 (1.5) | 11 (1.5) | 19 (0.6) | 65 (2.3) | 50 (0.5) |
Depressive symptoms (CES-D score) | |||||||
Absence (Less than 16) | 36,098 (70.8) | 12,200 (67.6) | 11,118 (72.5) | 522 (70.7) | 2,280 (71.7) | 1,881 (67.3) | 8,097 (74.5) |
Presence (16 or more) | 12,388 (24.3) | 4,491 (24.9) | 3,620 (23.6) | 176 (23.9) | 814 (25.6) | 770 (27.5) | 2,517 (23.2) |
Unknown | 2,481 (4.9) | 1,358 (7.5) | 605 (3.9) | 40 (5.4) | 84 (2.6) | 146 (5.2) | 248 (2.3) |
CSC, Community Support Centers (Established by ToMMo in seven areas in Miyagi Prefecture).
Association between baseline survey participation type and the second period survey characteristics
Figure 2 shows the ORs and 95% CIs for logistic regression analyses of lifestyle, physical, and psychological factors according to participation type, with adjustments for the abovementioned characteristics. Compared to Type 1 without CSC survey participants, Type 2 participants had higher odds of ever drinking (adjusted OR 1.14; 95% CI, 1.08–1.20) and less time spent walking (adjusted OR 1.25; 95% CI, 1.18–1.31) with lower odds of having a 25 kg/m2 or more BMI (adjusted OR 0.76; 95% CI, 0.72–0.81), and higher odds of perceived stress (adjusted OR 1.07; 95% CI, 1.004–1.13), psychological distress (adjusted OR 1.26; 95% CI, 1.06–1.50), and depressive symptoms (adjusted OR 1.07; 95% CI, 1.003–1.14). Additionally, Type 1 with CSC survey participants were associated with lower odds of an ever-smoker status (adjusted OR 0.88; 95% CI, 0.80–0.97), lower odds of having a 25 kg/m2 or more BMI (adjusted OR 0.91; 95% CI, 0.83–0.99), and higher odds of having psychological distress (adjusted OR 1.36; 95% CI, 1.04–1.77) compared to Type 1 without CSC survey participants.
DISCUSSION
This paper provides an overview of the Miyagi Prefecture part of the second period survey of the TMM CommCohort Study. Nearly half of the 33,392 Type 1 without CSC survey participants in the baseline survey who visited only their municipalities’ specific health checkup venues also visited the regional support center and provided more detailed data. Furthermore, approximately 80% of the 17,575 participants who visited the CSC in the baseline survey subsequently attended the CSC during the second period survey. This allowed us to evaluate changes in health information, as shown in Table 2 and Table 3. We could also collect extensive data for approximately 30,000 participants in the second period survey.
Characteristics of the second period survey participants
The second period survey participants may have had higher health consciousness and better health condition than the non-participants. Notably, these survey participants had a high percentage of never-smokers, individuals with a <25 kg/m2 BMI, and fewer depressive symptoms. Considering that the study included a healthy sample, the prevalence of diseases in real-life may have been underestimated; thus, caution is required in generalizing the study findings. However, participation rate was high, especially in participants who had visited CSC in baseline survey.
Type 1 with CSC survey and Type 2 survey respondents participated in a detailed survey by voluntarily visiting the CSC at baseline. Participants who voluntarily visited the CSC at the baseline survey may have been more interested in their health than the other participants, and they more actively participated in the second period survey. However, we hypothesized that Type 1 without CSC survey respondents might be health-conscious individuals receiving municipal-specific health checkups.3 When we examined whether lifestyle, physical, and psychological factors differed between the participation types after controlling for differences in sex, age, and social background, we found that Type 2 participants were more likely to consume alcoholic drinks, walk for less than an hour, and have a BMI of ≥25 kg/m2, perceived stress, psychological distress, and depressive symptoms. Although second period survey participants generally share the same characteristics, there are some variables that differ depending on the type of participation and need to be handled with care.
Newly added variables in the second period survey
Some variables not considered in the baseline survey were added to the second period survey. For example, the questionnaire asked for information on, income, physical damage caused by the earthquake, participation in evacuation drills, Helicobacter pylori eradication status, vaccination behavior, and family care. C-reactive protein, fraction of exhaled nitric oxide, electrocardiogram, and taste of salt were added to the blood and urine tests in the baseline survey. The inclusion of these variables enabled a more detailed examination of the effects of the earthquake-related disaster and elucidation of issues, such as aging and infectious diseases, which have become public health concerns. The advantage of a face-to-face survey is that it allows the timely collection of required data, and we can proceed with a cohort study after this survey.
Furthermore, by establishing this cohort, many additional studies have become feasible, and industry-academia collaboration is steadily progressing. We are working on producing a Na/K ratio meter, an activity tracker, and a sleep meter with OMRON Healthcare Co., Ltd., as well as researching lacto-fermented beverage consumption and intestinal flora with Yakult Central Institute.
The strength of our study is that this cohort is one of Japan’s largest to be included in a prospective study, with extensive evaluations that are not commonly performed at regular health checkups. There are larger prospective cohorts with extensive evaluations, such as the Hisayama study18,19 and the Nagahama study.20 We performed 14,000 extensive evaluations (ie, there were 14,000 participants who visited the CSC at both baseline and second period surveys). These numbers were comparable to the aforementioned studies. Furthermore, the second period survey alone resulted in the creation of a massive database of approximately 30,000 people. The study information can be used to establish a database for observing changes in test values in conjunction with baseline surveys, as well as a large database for the next repeated center-based survey during the third period. Databases containing information on motor, visual, and auditory functions are particularly valuable in an aging society.
As with other prospective studies, our study has limitations. The participation ratio in the second period survey was approximately 60%. It is possible that these participants were healthier or more interested than non-participants. However, approximately 80% of individuals who visited CSC for the baseline survey attended the subsequent second period survey. Furthermore, despite not participating in the second period survey, 50,967 (98%) of the 51,850 individuals who completed the baseline survey continued to participate in the follow-up survey (ie, mail survey and survey based on public information, indicating a remarkably high follow-up rate).
Conclusion
Following up the participants elucidated the long-term effects of disaster-related factors on health. By examining data from repeated measures, it is expected that future studies will be able to clarify the association between changes in survey items and the onset of disease. We also have genomic and other omics data,1,21,22 and by using this cohort, we could clarify the long-term effects of earthquake-related disaster and contribute to illness prevention and individualized treatment. Furthermore, we promote the use of these data in collaborative research.
ACKNOWLEDGMENTS
The authors express their sincere gratitude for their valuable support to the GEJE-affected areas after the disaster. We also thank all the participants and municipal staff who helped with our project. We appreciate the members of ToMMo and IMM, including GMRCs, office and administrative personnel, and software engineers, for their assistance with the projects. The complete lists of ToMMo and IMM members are available at https://www.megabank.tohoku.ac.jp/english/a220901/ for ToMMo and http://iwate-megabank.org/en/about/departments/ for IMM.
Data availability: The TMM data-sharing policy is publicly available at http://www.megabank.tohoku.ac.jp/english/sample/. Request for use of the TMM biobank data for research purposes should be made by applying to the ToMMo headquarters. All requests are subject to approval by the Sample and Data Access Committee. Details are available upon request at dist@megabank.tohoku.ac.jp.
List of funding sources: TMM is supported by grants from Reconstruction Agency, Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Japan Agency for Medical Research and Development (AMED) (JP17km0105001, JP21tm0124005). Supercomputer resource (powered by AMED research grant JP22tm0424601) and dbTMM were provided by Tohoku Medical Megabank Organization, Tohoku University.
Conflicts of interest: None declared.
REFERENCES
- 1.Kuriyama S, Yaegashi N, Nagami F, et al. The Tohoku Medical Megabank Project: design and mission. J Epidemiol. 2016;26:493–511. 10.2188/jea.JE20150268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kuriyama S, Metoki H, Kikuya M, et al. Cohort profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective. Int J Epidemiol. 2020;49:18–19m. 10.1093/ije/dyz169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hozawa A, Tanno K, Nakaya N, et al. Study profile of the Tohoku Medical Megabank Community-Based Cohort Study. J Epidemiol. 2021;31:65–76. 10.2188/jea.JE20190271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Takase M, Yamada M, Nakamura T, et al. The association of lung function and carotid intima-media thickness in a Japanese population: the Tohoku Medical Megabank Community-Based Cohort Study. J Atheroscler Thromb. 2023;30(8):1022–1044. 10.5551/jat.63826 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kanno I, Hasegawa K, Nakamura T, et al. Relationship between the housing coldness/warmth evaluation by CASBEE Housing Health Checklist and psychological distress based on TMM Community-Based Cohort Study: a cross-sectional analysis. Public Health. 2022;208:98–104. 10.1016/j.puhe.2022.05.003 [DOI] [PubMed] [Google Scholar]
- 6.Takase M, Nakamura T, Nakaya N, et al. Associations between the combined fat mass index and fat-free mass index with carotid intima-media thickness in a Japanese population: the Tohoku Medical Megabank Community-Based Cohort Study. J Atheroscler Thromb. 2023;30:255–273. 10.5551/jat.63523 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Itabashi F, Hirata T, Kogure M, et al. Combined associations of liver enzymes and obesity with diabetes mellitus prevalence: the Tohoku Medical Megabank Community-based Cohort Study. J Epidemiol. 2022;32:221–227. 10.2188/jea.JE20200384 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Takase M, Nakamura T, Hirata T, et al. Association between fat mass index, fat-free mass index and hemoglobin A1c in a Japanese population: the Tohoku Medical Megabank Community-based Cohort Study. J Diabetes Investig. 2022;13:858–867. 10.1111/jdi.13729 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fuse N, Sakurai M, Motoike IN, et al. Genome-wide association study of axial length in population-based cohorts in Japan: the Tohoku Medical Megabank Organization Eye Study. Ophthalmol Sci. 2022;2:100113. 10.1016/j.xops.2022.100113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Takase M, Nakamura T, Tsuchiya N, et al. Association between the combined fat mass and fat-free mass index and hypertension: the Tohoku Medical Megabank Community-based Cohort Study. Clin Exp Hypertens. 2021;43:610–621. 10.1080/10641963.2021.1925681 [DOI] [PubMed] [Google Scholar]
- 11.Tashiro A, Kogure M, Nagata S, et al. Coastal exposure and residents’ mental health in the affected areas by the 2011 Great East Japan Earthquake and Tsunami. Sci Rep. 2021;11:16751. 10.1038/s41598-021-96168-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lubben J, Blozik E, Gillmann G, et al. Performance of an abbreviated version of the Lubben Social Network Scale among three European Community-dwelling older adult populations. Gerontologist. 2006;46:503–513. 10.1093/geront/46.4.503 [DOI] [PubMed] [Google Scholar]
- 13.Drossman DA, Talley NJ, Whitehead WE, Corazziari E. Research diagnostic questions for functional gastrointestinal disorders: Rome II Modular Questionnaire: Investigations and respondent forms. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, eds. Rome II The Functional Gastrointestinal Disorders. second ed. McLean: Degnon Associates; 2000:669–714. [Google Scholar]
- 14.Shinozaki M, Kanazawa M, Sagami Y, et al. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol. 2006;41:491–494. 10.1007/s00535-006-1799-9 [DOI] [PubMed] [Google Scholar]
- 15.Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. 10.1177/014662167700100306 [DOI] [Google Scholar]
- 16.Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–976. 10.1017/S0033291702006074 [DOI] [PubMed] [Google Scholar]
- 17.Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res. 2003;55:263–267. 10.1016/S0022-3999(02)00604-9 [DOI] [PubMed] [Google Scholar]
- 18.Hata J, Ninomiya T, Hirakawa Y, et al. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961–2009). Circulation. 2013;128:1198–1205. 10.1161/CIRCULATIONAHA.113.002424 [DOI] [PubMed] [Google Scholar]
- 19.Ninomiya T. Japanese legacy cohort studies: the Hisayama Study. J Epidemiol. 2018;28:444–451. 10.2188/jea.JE20180150 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Matsumoto T, Murase K, Tabara Y, et al. Impact of sleep characteristics and obesity on diabetes and hypertension across genders and menopausal status: the Nagahama study. Sleep. 2018;41. 10.1093/sleep/zsy071 [DOI] [PubMed] [Google Scholar]
- 21.Fuse N, Sakurai-Yageta M, Katsuoka F, et al. Establishment of integrated biobank for precision medicine and personalized healthcare: the Tohoku Medical Megabank Project. JMA J. 2019;2:113–122. 10.31662/jmaj.2019-0014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Koshiba S, Motoike I, Saigusa D, et al. Omics research project on prospective cohort studies from the Tohoku Medical Megabank Project. Genes Cells. 2018;23:406–417. 10.1111/gtc.12588 [DOI] [PubMed] [Google Scholar]